Synergy Asset Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Synergy Asset Management’s Portfolio TLIS Stock Details TLIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14	Closed	-$26	–	911
2024 Q4	$26	Buy	+14	New	+$26	﹤0.01%	870

Synergy Asset Management's TLIS Position: Q1 2025 in Review

Synergy Asset Management sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q1 2025, closing a stake of 14 shares — an estimated $26 sold.

Synergy Asset Management first reported a position in TLIS in Q4 2024 and held it in 1 quarter. The position peaked at $26 in Q4 2024. 0 funds tracked by Wall St. Rank hold TLIS as of Q1 2025.

Synergy Asset Management reported no remaining Talis Biomedical Corporation Common Stock position as of Q1 2025 after selling out during the quarter.
Synergy Asset Management sold 14 Talis Biomedical Corporation Common Stock shares in Q1 2025, an estimated $26.
Synergy Asset Management first reported a position in Talis Biomedical Corporation Common Stock in Q4 2024 and held it in 1 quarter.
Synergy Asset Management's Talis Biomedical Corporation Common Stock position peaked at $26 in Q4 2024.
0 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q1 2025.

Based on Synergy Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.